Functional magnetic resonance imaging of effects of a nicotinic agonist in schizophrenia.

Find People
Find Research
Overview
Tutorials
FAQs
Edit My PROFILE
Login to PROFILES

History

An enzyme-sensitive PE

A LC-MS/MS Method for

Enhancing the detectio

In situ forming degrad

Functional magnetic re

See All (15) pages

Contact Us
If you have any questions or feedback please contact us.

Functional magnetic resonance imaging of effects of a nicotinic agonist in schizophrenia.

Tregellas JR, Olincy A, Johnson L, Tanabe J, Shatti S, Martin LF, Singel D, Du YP, Soti F, Kem WR, Freedman R. Functional magnetic resonance imaging of effects of a nicotinic agonist in schizophrenia. Neuropsychopharmacology. 2010 Mar; 35(4):938-42.

View in: PubMed

subject areas

Adult
Benzylidene Compounds
Brain
Brain Mapping
Cross-Over Studies
Dose-Response Relationship, Drug
Double-Blind Method
Female
Humans
Image Processing, Computer-Assisted
Magnetic Resonance Imaging
Male
Middle Aged
Nicotinic Agonists
Oxygen
Pyridines
Schizophrenia

authors with profiles

Jody Lee Tanabe
Jason R Tregellas
Robert Freedman

Contact Us
CCTSI
About CCTSI
CCTSI Affiliated Institutions
National CTSA Consortium